Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial | medRxiv

Article usage

Article usage: May 2020 to October 2021

	Abstract	Full	Pdf
May 2020	1898	0	236
Jun 2020	2609	0	729
Jul 2020	2038	0	570
Aug 2020	1004	0	295
Sep 2020	478	0	180
Oct 2020	385	0	128
Nov 2020	336	0	156
Dec 2020	330	1	114
Jan 2021	284	6	111
Feb 2021	184	1	57
Mar 2021	118	6	74
Apr 2021	157	2	111
May 2021	176	4	81
Jun 2021	134	0	78
Jul 2021	104	5	83
Aug 2021	121	6	59
Sep 2021	157	3	68
Oct 2021	94	3	23

View the discussion thread.

Posted May 30, 2020.

Subject Area

Infectious Diseases (except HIV/AIDS)

Subject Areas

All Articles

Addiction Medicine (110)
Allergy and Immunology (298)
Anesthesia (73)
Cardiovascular Medicine (658)
Dentistry and Oral Medicine (120)
Dermatology (77)
Emergency Medicine (214)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (297)
Epidemiology (7210)
Forensic Medicine (4)
Gastroenterology (301)
Genetic and Genomic Medicine (1278)
Geriatric Medicine (124)
Health Economics (305)
Health Informatics (997)
Health Policy (520)
Health Systems and Quality Improvement (354)
Hematology (150)
HIV/AIDS (280)
Infectious Diseases (except HIV/AIDS) (8461)
Intensive Care and Critical Care Medicine (480)
Medical Education (159)
Medical Ethics (39)
Nephrology (149)
Neurology (1221)
Nursing (63)
Nutrition (195)
Obstetrics and Gynecology (253)
Occupational and Environmental Health (364)
Oncology (693)
Ophthalmology (213)
Orthopedics (68)
Otolaryngology (137)
Pain Medicine (72)
Palliative Medicine (30)
Pathology (195)
Pediatrics (406)
Pharmacology and Therapeutics (195)
Primary Care Research (158)
Psychiatry and Clinical Psychology (1351)
Public and Global Health (3030)
Radiology and Imaging (500)
Rehabilitation Medicine and Physical Therapy (242)
Respiratory Medicine (413)
Rheumatology (157)
Sexual and Reproductive Health (115)
Sports Medicine (113)
Surgery (150)
Toxicology (32)
Transplantation (66)
Urology (50)